Noida Chronicle

BK virus Infection Market Insights, Drugs and Market Assessment by DelveInsight

 Breaking News
  • No posts were found

BK virus Infection Market Insights, Drugs and Market Assessment by DelveInsight

January 19
10:05 2021
BK virus Infection Market Insights, Drugs and Market Assessment by DelveInsight

DelveInsight has launched a new report on BK virus Infection Market

BK virus (BKV) infection also known as polyomavirus is a member of the human polyomavirus family. BKV resides dormant in uroepithelial cells as it is mostly acquired in childhood and is not known to cause tissue damage in immunocompetent individuals. The virus can become reactivated in case of immunodeficiency (e.g., secondary to HIV infection or immunosuppressive medications), and result in cellular damage and organ dysfunction.

Request for free sample copy- https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-market

BK virus Infection detailed Market size by therapies, covering the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan from 2017-2030

BK virus Infection Treatment

Other treatment alternatives can include use of ciprofloxacin, rapamycin or intravenous immunoglobulin. Intravenous immunoglobulin (IVIG) is a non-depleting agent, with antiviral and immunomodulatory properties.

Key player of the report

  • SL VAXiGEN

BK virus Infection Market Insights

BK polyomavirus causes frequent infections during childhood and establishes persistent infections within renal tubular cells and the uroepithelium, with minimal clinical implications. BK polyomavirus (BKV) is a member of the Polyomaviridae family of double-stranded DNA (dsDNA) viruses. However, the reactivation of the infection of BKV in immunocompromised individuals following renal or hematopoietic stem cell transplantation may cause serious complications, including BKV-associated nephropathy (BKVAN), ureteric stenosis, or hemorrhagic cystitis.

BK virus Infection Market Size

The dynamics of BK virus (BKV) Infection market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies and incremental healthcare spending across the world. The launch of emerging therapies is expected during the forecast period of 2020–2030.

Owing to the positive outcomes of the some of the rare candidates during the developmental stage by key players, such as SL VAXiGEN (SL-V10), and others companies that are under preclinical phase of development have the potential to create a significant positive shift in BK virus infection in the market size.

BK virus Infection Market Report Highlights

  • In the coming years, BK virus (BKV) Infection market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
  • The companies and academics are working to assess challenges and seek opportunities that could influence BK virus (BKV) Infection R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition       
  • Major players are involved in developing therapies for BK virus (BKV) Infection. Launch of emerging therapies will significantly impact the BK virus (BKV) Infection market
  • A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for BK virus (BKV) Infection
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Request for free sample copy- https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-market

Table of content

1. Key Insights

2. Executive Summary of BK virus (BKV) Infection

3. Competitive Intelligence Analysis for BK virus (BKV) Infection

4. BK virus (BKV) Infection: Market Overview at a Glance

5. BK virus (BKV) Infection: Disease Background and Overview

6. Patient Journey

7. BK virus (BKV) Infection Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of BK virus (BKV) Infection Treatment

11. Marketed Products

12. Emerging Therapies

13. BK virus (BKV) Infection: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size

16. Access and Reimbursement Overview of BK virus (BKV) Infection

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Why should you buy this report?

  • The report will help in developing business strategies by understanding trends shaping and driving the BK virus (BKV) Infection market
  • To understand the future market competition in the BK virus (BKV) Infection market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for BK virus (BKV) Infection in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for BK virus (BKV) Infection market
  • To understand the future market competition in the BK virus (BKV) Infection market

Related reports

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Related Articles